GlobalData
GlobalData

Sophie Clinton

  • Home
  • Author: Sophie Clinton

FDA rejection of Breztri Aerosphere strains AstraZeneca’s competitive edge in COPD

Following the recent announcement (Tuesday 1 October) that the Food and Drug Administration (FDA) has issued a complete response letter for the New Drug Application (NDA) for PT010 (budesonide/glycopyrronium/formoterol fumarate); Paul Jeng, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers his perspective: “In an attempt to close the gap with chief […]
Read more

Telecom companies to play a more pivotal role in gaming industry

The gaming industry is moving to an as-a-service business model where customers can immediately purchase and play games without the need for equipment such as consoles. In response, industry players such as phone companies are shifting their offers towards cloud gaming and streaming services, according to GlobalData, a leading data and analytics company. GlobalData’s latest […]
Read more

Saudi Arabia must ensure benefits of change are inclusive with the opening of the tourism sector

Following the news (Friday 27 September) that Saudi Arabia has introduced reforms to its visa regulations and dress-code restrictions for women to encourage foreign tourists; Richard Thompson, Editorial Director at GlobalData, a leading data and analytics company, offers his view on Saudi Arabia’s tourism market: “The opening up of Saudi Arabia’s tourism market to international visitors […]
Read more

Biogen’s new trial may score a win for late-onset SMA patients

Following the news that Biogen will initiate a new clinical trial DEVOTE that will evaluate higher doses of Spinraza; Vinie Varkey, Senior Neurology and Ophthalmology Analyst at GlobalData, a leading data and analytics company, offers her view on the implications of this trial for the spinal muscular atrophy (SMA) market: “The results of this trial, […]
Read more

Potential first-in-class CMV therapeutic TAK-620 set to reach global sales of $7.1m by 2027

Following the publication (Wednesday 25 September) of new Phase II data for Takeda’s TAK-620 (maribavir) as treatment for cytomegalovirus (CMV) infections in recipients of hematopoietic cell or solid organ transplant; Paul Jeng, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers his perspective: “TAK-620 performed favorably in virus clearance compared to the […]
Read more

North America to contribute 82% of global LNG liquefaction capacity additions by 2023

North America is expected to drive global liquefied natural gas (LNG) liquefaction capacity growth through planned and announced (new-build) projects between 2019 and 2023, contributing around 82% of the total growth, according to GlobalData, a leading data and analytics company. The company’s report, ‘H2 2019 Global Capacity and Capital Expenditure Outlook for LNG Liquefaction Terminals […]
Read more

Thomas Cook collapse down to failure to understand its own industry

Following the recent news (Monday 23 September) that Britain’s oldest travel agent has collapsed; Cyrus Mewawalla, Head of Thematic Research at GlobalData, a leading data and analytics company, offers his view on what caused the travel company’s demise: “Travel company Thomas Cook’s collapse is a direct result of the company’s failure to understand the disruptive […]
Read more

Gazprom to lead global gas processing capacity additions by 2023

Gazprom is expected to lead new-build gas processing capacity additions in the global gas processing industry from planned and announced (new-build) projects between 2019 and 2023, contributing around 13% to global gas processing capacity growth by 2023, according to GlobalData, a leading data and analytics company. The company’s report, ‘Global Capacity and Capital Expenditure Outlook […]
Read more

Biotronik sets high expectations for MDR certification among European medical device manufacturers

Following the recent news (Wednesday 18 September) that Biotronik has obtained European Medical Device Regulation (MDR) certification for a Class III (highest risk) medical device; Ashley Young, PhD, Medical Analyst at GlobalData, a leading data and analytics company, offers her view on the implications of this certification: “Biotronik becoming the first medical device manufacturer to […]
Read more
1 8 9 10 11 12 13